Marketa Vondrousova, the Czech player who became Wimbledon’s first unseeded women’s champion when she won the title in 2023, has been suspended for four years by an independent anti-doping tribunal after refusing to submit a sample during an out-of-competition test at her home last December.
The International Tennis Integrity Agency confirmed the ban on Monday, stating that Vondrousova had declined to provide a sample when a doping control officer arrived at her home at around 8 p.m. on December 3, 2025, and that she had instead signed a refusal form. The suspension runs through June 21, 2030, and can be appealed to the Court of Arbitration for Sport in Switzerland.
Vondrousova’s explanation and the tribunal’s response
Vondrousova had addressed the incident publicly in April, describing a period of sustained physical and mental stress that she said brought her to a breaking point. She also raised concerns about the circumstances of the test itself, stating that the person who arrived at her door that night did not properly identify herself as a doping control officer before Vondrousova was expected to comply.
In her public statement following the ruling, Vondrousova was emphatic that she had never tested positive for a prohibited substance throughout her career and that a test conducted three days after the refusal also returned a negative result. She described the incident as one that had changed her life and sought to contextualize it within a mental health crisis rather than any intent to avoid scrutiny.
The tribunal considered both the mental health testimony and a separate account provided by the doping control officer who attempted to conduct the test. It concluded that the evidence offered no compelling justification for the refusal and upheld the four-year sanction, which represents the standard starting point under anti-doping rules for a test refusal.
Why refusal carries the same weight as a positive test
The ITIA’s chief executive addressed the logic behind the sanction directly, explaining that the anti-doping framework must maintain the principle that refusing a test cannot place an athlete in a more advantageous position than simply taking it and testing positive. If refusals were treated more leniently, athletes facing a positive test would have an incentive to refuse rather than submit, undermining the entire verification system.
The agency also highlighted the importance of unannounced testing as a tool for maintaining clean sport, noting that athletes can be tested at any time and in any location, and that this unpredictability is essential to the system’s integrity. Athletes are required to designate a one-hour window each day during which they guarantee availability for testing, but they are also required to submit if located during a surprise visit outside that window. Not being home during an unannounced visit carries no sanction. Refusing when found does.
A high-profile case in a sport managing its testing reputation
Vondrousova’s case arrives at a moment when tennis has faced repeated scrutiny over how doping matters are handled at the highest level. Three other prominent players have navigated anti-doping cases in recent years, each successfully arguing that they bore no significant fault for their positive results. Vondrousova’s situation is structurally different in that no positive test exists, but the precedent of those earlier cases and the public discussion they generated has added context to how this ruling is being received.
Vondrousova was represented by a Los Angeles-based attorney who previously helped another former Grand Slam champion successfully appeal a four-year ban at the Court of Arbitration for Sport. That option remains open to Vondrousova, and whether she pursues it will determine whether this suspension stands or is reduced.
Wimbledon, the tournament Vondrousova won less than three years ago, begins next week.
